- Home
- FWDI vs VCRE Comparison
FWDI vs VCRE Comparison
Compare FWDI & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FWDI | VCRE |
|---|---|---|
| Founded | 1961 | N/A |
| Country | United States | Sweden |
| Employees | N/A | 40 |
| Industry | Plastic Products | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 325.3M | 332.9M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FWDI | VCRE |
|---|---|---|
| Price | $4.14 | $12.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 782.3K | 2.4K |
| Earning Date | 05-13-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,187,525.00 | N/A |
| Revenue This Year | $407.02 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.48 | $10.50 |
| 52 Week High | $9.28 | $12.85 |
Technical Indicators
Market Signals| Indicator | FWDI | VCRE |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 48.32 |
| Support Level | $4.07 | $11.00 |
| Resistance Level | $5.17 | $12.85 |
| Average True Range (ATR) | 0.23 | 0.31 |
| MACD | 0.02 | 0.14 |
| Stochastic Oscillator | 46.94 | 75.89 |
Price Performance
Historical ComparisonAbout FWDI Forward Industries Inc.
Forward Industries Inc is a Solana-focused digital asset treasury company, with the idea to buy, hold, stake, trade, invest in, and grow SOL and SOL-related digital assets, protocols, and businesses. Its mission is to expand and strengthen the Solana ecosystem by acquiring and staking SOL and engaging with, providing tools to, and investing in the Solana network, Solana developers, and Solana-related projects in order to increase shareholder value. In connection with a private placement transaction in September 2025, it launched a digital asset treasury idea supported by investors and operating partners, including Galaxy Digital and Jump Crypto.
About VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.